Yunzhi Pan

753 total citations
30 papers, 543 citations indexed

About

Yunzhi Pan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yunzhi Pan has authored 30 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Yunzhi Pan's work include MicroRNA in disease regulation (5 papers), Cancer Cells and Metastasis (5 papers) and RNA Interference and Gene Delivery (4 papers). Yunzhi Pan is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer Cells and Metastasis (5 papers) and RNA Interference and Gene Delivery (4 papers). Yunzhi Pan collaborates with scholars based in China, Mexico and Singapore. Yunzhi Pan's co-authors include Sai Ma, Long Yu, Chuanwu Zhu, Lichao Sun, Yuliang Ran, Xiong Shu, Kai‐Yue Cao, Lixin Sun, Chao Gao and Guangfei Li and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Gene.

In The Last Decade

Yunzhi Pan

29 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunzhi Pan China 13 320 159 117 58 52 30 543
Zhaowei Zou China 11 283 0.9× 148 0.9× 78 0.7× 72 1.2× 53 1.0× 20 454
Shan Cheng China 18 377 1.2× 108 0.7× 109 0.9× 93 1.6× 54 1.0× 67 734
Jinbo Yuan China 16 401 1.3× 101 0.6× 189 1.6× 37 0.6× 48 0.9× 35 667
Lu Hao China 13 321 1.0× 123 0.8× 131 1.1× 114 2.0× 51 1.0× 50 548
Lijuan He China 14 339 1.1× 136 0.9× 107 0.9× 28 0.5× 74 1.4× 47 669
Jimin Yuan China 11 532 1.7× 208 1.3× 124 1.1× 71 1.2× 84 1.6× 20 782
Jin Zheng China 16 388 1.2× 129 0.8× 82 0.7× 50 0.9× 114 2.2× 36 693
Dezhi Song China 15 482 1.5× 142 0.9× 222 1.9× 44 0.8× 97 1.9× 37 717
Mohsen Karami Fath Iran 12 338 1.1× 159 1.0× 105 0.9× 41 0.7× 61 1.2× 28 496
Vid Mlakar Slovenia 14 332 1.0× 130 0.8× 101 0.9× 41 0.7× 40 0.8× 28 603

Countries citing papers authored by Yunzhi Pan

Since Specialization
Citations

This map shows the geographic impact of Yunzhi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunzhi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunzhi Pan more than expected).

Fields of papers citing papers by Yunzhi Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunzhi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunzhi Pan. The network helps show where Yunzhi Pan may publish in the future.

Co-authorship network of co-authors of Yunzhi Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yunzhi Pan. A scholar is included among the top collaborators of Yunzhi Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunzhi Pan. Yunzhi Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiangxiang, Lu Diao, Jin Wang, et al.. (2025). Maximizing Efficacy of Cancer Nanovaccines and Immune Cells Landscape in Responders and Non‐Responders to Immunotherapy (Adv. Sci. 35/2025). Advanced Science. 12(35). 4 indexed citations
2.
4.
Zhao, Aiqin, Yunzhi Pan, Zheng Zhi, et al.. (2024). MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3. BMC Cancer. 24(1). 559–559. 3 indexed citations
5.
Pan, Yunzhi, et al.. (2023). ANXA2 as a novel substrate of FBXW7 promoting esophageal squamous cell carcinoma via ERK phosphorylation. Biochemical and Biophysical Research Communications. 649. 93–100. 7 indexed citations
6.
Pan, Yunzhi, Jing Liu, Changxing Wang, et al.. (2023). FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation. Journal of Experimental & Clinical Cancer Research. 42(1). 75–75. 12 indexed citations
7.
Pan, Yunzhi, et al.. (2022). Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer. Pharmaceutical Research. 40(1). 265–279. 19 indexed citations
8.
Diao, Lu, Lin Ma, Yunzhi Pan, et al.. (2022). Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis. iScience. 25(12). 105511–105511. 12 indexed citations
9.
Ma, Sai, Bo Zhou, Qian Yang, et al.. (2021). A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma. Cancer Research. 81(5). 1216–1229. 60 indexed citations
10.
Pan, Yunzhi, Peijun Tang, Jun Cao, et al.. (2020). Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction. Biochemical and Biophysical Research Communications. 533(4). 1512–1518. 33 indexed citations
11.
Li, Xiao, Dixian Luo, Weihao Luo, et al.. (2019). Primerless Amplification for Circulating Tumor DNA Assays. Journal of Biomedical Nanotechnology. 15(5). 1052–1060. 1 indexed citations
12.
Guo, Jia, Mengjiao Zhou, Xin Liu, et al.. (2018). Porcine IFI30 inhibits PRRSV proliferation and host cell apoptosis in vitro. Gene. 649. 93–98. 9 indexed citations
13.
Zhou, Mengjiao, Xiaojun Zhang, Yunzhi Pan, et al.. (2016). miRNA29 Promotes Viral Replication During Early Stage of PRRSV Infection In Vitro. DNA and Cell Biology. 35(10). 636–642. 16 indexed citations
14.
Fang, Xibi, Ping Jiang, Hang Xiao, et al.. (2016). <i>AGPAT6</i> gene EX1_303T > C and EX12_299G > A mutations and associations with economic traits of Chinese Simmental-cross cattle. Archives animal breeding/Archiv für Tierzucht. 59(2). 301–307. 1 indexed citations
15.
Pan, Yunzhi, et al.. (2016). Antihypoxic effect of miR-24 in SH-SY5Y cells under hypoxia via downregulating expression of neurocan. Biochemical and Biophysical Research Communications. 477(4). 692–699. 9 indexed citations
16.
Liang, Wenna, Xiaoyang Zhao, Jinping Feng, Fenghua Song, & Yunzhi Pan. (2016). Ursolic acid attenuates beta-amyloid-induced memory impairment in mice. Arquivos de Neuro-Psiquiatria. 74(6). 482–488. 32 indexed citations
17.
Pan, Yunzhi, Wenna Liang, Xiaoyang Zhao, et al.. (2016). miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2. Neuroreport. 27(17). 1266–1273. 14 indexed citations
18.
Pan, Yunzhi, Xiao Li, Xu Zhang, et al.. (2012). Biological and Biomedical Applications of Engineered Nucleases. Molecular Biotechnology. 55(1). 54–62. 26 indexed citations
19.
Wang, Qinglin, Weida Wang, Yunzhi Pan, et al.. (2012). A Mutation-Sensitive Switch Based Assay for Code 1493 of APC Gene. Advanced Science Letters. 11(1). 53–56. 1 indexed citations
20.
He, Nongyue, Xin Zeng, Weida Wang, et al.. (2011). Challenges and Future Expectations of Reversed Gene Therapy. Journal of Nanoscience and Nanotechnology. 11(10). 8634–8638. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026